Halyard Health Inc. (NYSE:HYH) shares saw unusually-high trading volume on Friday . Approximately 970,479 shares were traded during mid-day trading, an increase of 168% from the previous session’s volume of 362,416 shares.The stock last traded at $34.59 and had previously closed at $34.35.

HYH has been the topic of a number of analyst reports. TheStreet raised Halyard Health from a “sell” rating to a “hold” rating in a research report on Friday, July 8th. JMP Securities reissued a “buy” rating on shares of Halyard Health in a research report on Tuesday, April 12th. Stifel Nicolaus raised their target price on Halyard Health from $32.00 to $37.00 and gave the stock a “buy” rating in a research report on Tuesday, June 14th. Zacks Investment Research raised Halyard Health from a “hold” rating to a “buy” rating and set a $33.00 target price on the stock in a research report on Friday, May 6th. Finally, Stephens initiated coverage on Halyard Health in a research report on Friday, April 8th. They set an “overweight” rating on the stock. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and five have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $33.80.

The company has a 50-day moving average of $33.24 and a 200-day moving average of $29.35. The stock’s market cap is $1.61 billion.

Halyard Health (NYSE:HYH) last posted its quarterly earnings results on Wednesday, May 4th. The company reported $0.53 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.34 by $0.19. During the same period last year, the firm posted $0.51 EPS. The firm had revenue of $385 million for the quarter, compared to analysts’ expectations of $369.80 million. Halyard Health’s revenue was down 2.3% on a year-over-year basis. On average, equities research analysts expect that Halyard Health Inc. will post $1.66 EPS for the current year.

A number of large investors have recently bought and sold shares of the stock. BlackRock Advisors LLC increased its stake in Halyard Health by 151.2% in the fourth quarter. BlackRock Advisors LLC now owns 533,462 shares of the company’s stock worth $17,823,000 after buying an additional 321,059 shares during the period. Wells Fargo & Company MN increased its stake in Halyard Health by 73.8% in the fourth quarter. Wells Fargo & Company MN now owns 581,871 shares of the company’s stock worth $19,440,000 after buying an additional 247,075 shares during the period. New York State Common Retirement Fund increased its stake in Halyard Health by 168.1% in the fourth quarter. New York State Common Retirement Fund now owns 147,992 shares of the company’s stock worth $4,944,000 after buying an additional 92,791 shares during the period. Cornerstone Capital Management Holdings LLC. purchased a new stake in Halyard Health during the fourth quarter worth about $1,454,000. Finally, First Trust Advisors LP purchased a new stake in Halyard Health during the fourth quarter worth about $1,234,000.

Halyard Health, Inc seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.